In contrast, the proportions of NKG2D+CD3+, NKG2D+CD8+, NKp30+CD3+, and NKp30+CD4+ T cells were significantly reduced in the ND-AML patients. The gene discussed is CD8A; the disease is acute myeloid leukemia.